PIK3CA and leukemia: Pathway analysis revealed enrichment in PI3K-AKT, MAPK, JAK-STAT, PD-1/PD-L1, and leukemia-specific signaling pathways, which are closely linked to AML carcinogenesis and drug resistance (Park et al., 2010).